No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial

The aim of this study was to evaluate the clinical effects of dexamethasone administration in patients with mild to moderate acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19). The study included 50 patients who were randomly assigned to the dexamethasone group or...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur J Pharmacol
Glavni autori: Jamaati, Hamidreza, Hashemian, Seyed MohammadReza, Farzanegan, Behrooz, Malekmohammad, Majid, Tabarsi, Payam, Marjani, Majid, Moniri, Afshin, Abtahian, Zahra, Haseli, Sara, Mortaz, Esmaeil, Dastan, Alireza, Mohamadnia, Abdolreza, Vahedi, Abdolbaset, Monjazebi, Fatemeh, Yassari, Fatemeh, Fadaeizadeh, Lida, Saffaei, Ali, Dastan, Farzaneh
Format: Artigo
Jezik:Inglês
Izdano: Elsevier B.V. 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885705/
https://ncbi.nlm.nih.gov/pubmed/33607104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2021.173947
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items